FilingReader Intelligence
Tiantan Biological announces dividend amid shareholder competition concerns
August 22, 2025 at 05:50 AM UTC•By FilingReader AI
Beijing Tiantan Biological Products Corp. announced a cash dividend of 0.15 yuan per share for the first half of 2025, totaling 296.6 million yuan.
The company also addressed new competition arising from controlling shareholder China National Biotec Group's acquisition of a 21.03% stake in Health Biopharma. China National Biotec Group pledged to resolve the competition within five years through asset restructuring.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Tiantan Biological 2025 semi-annual reportAugust 21, 2025 at 08:00 AM UTC
Special report on the deposit and actual use of raised funds for Sinopharm Tiantan Bio Group Co., Ltd. for the first half of 2025August 21, 2025 at 08:00 AM UTC
Announcement of resolutions from the 24th meeting of the 9th board of directors of Tiantan biological.August 21, 2025 at 08:00 AM UTC
Beijing Tiantan Biological Products company's report on the continuous risk assessment of Sinopharm Group Finance Company limitedAugust 21, 2025 at 08:00 AM UTC
Tiantan Biological 2025 semi-annual report summaryAugust 21, 2025 at 08:00 AM UTC
Beijing Tiantan Biological Products co., ltd. announcement regarding the actual controller and controlling shareholder's commitment concerning horizontal competitionAugust 21, 2025 at 08:00 AM UTC
SSE:600161•Shanghai Stock Exchange
Pharmaceuticals
News Alerts
Get instant email alerts when Beijing Tiantan Biological Products Corp publishes news
Free account required • Unsubscribe anytime